Literature DB >> 8371031

Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.

N T Foss1, E B de Oliveira, C L Silva.   

Abstract

The complex symptoms observed in lepromatous leprosy patients with reactive episodes of the erythema nodosum leprosum (ENL) type are associated with different serum components actively participating in the acute inflammatory reaction. Among them are the tumor necrosis factor (TNF) and the acute-phase protein C-reactive protein (CRP). TNF and CRP were found at significantly more elevated concentrations in the serum of patients with ENL, with a positive correlation of about 95% when compared with patients with nonreactive lepromatous leprosy (L) or tuberculoid leprosy (T) or with control individuals. Furthermore, in another series of experiments CRP had a specific and significant suppressive action on concanavalin A (ConA)-induced lymphoproliferation in cultures from patients and controls, the reduction being more marked (75%) in patients with ENL. By extrapolation from its known actions, production of TNF may have a number of potential consequences for the immunobiology of ENL. Thus, TNF may cause direct injury to compromised cells, facilitating mononuclear cell activation and production of cytokines such as interleukin-1 and interleukin-6, and upregulating hepatocyte expression of CRP. Both CRP and TNF in high serum concentrations have the ability to enhance the acute inflammatory process in ENL, favoring increased macrophage activation and phagoctyosis, and contributing to the elimination of damaged cells and bacilli, as well as in the reduction of T-suppressor cells, with a consequent improvement in the immunologic response of ENL patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371031

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  12 in total

1.  Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).

Authors:  E P Sampaio; M O Moraes; J A Nery; A R Santos; H C Matos; E N Sarno
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Involvement of TNF-Producing CD8+ Effector Memory T Cells with Immunopathogenesis of Erythema Nodosum Leprosum in Leprosy Patients.

Authors:  Pedro Henrique L Silva; Luciana N Santos; Mayara A Mendes; José A C Nery; Euzenir N Sarno; Danuza Esquenazi
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

Review 3.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

4.  Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day.

Authors:  Maria Stella de Mello Ayres Putinatti; Joel Carlos Lastória; Carlos Roberto Padovani
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

5.  Differential correlation between interleukin patterns in disseminated and chronic human paracoccidioidomycosis.

Authors:  C L Silva; M F Silva; L H Faccioli; R C Pietro; S A Cortez; N T Foss
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

6.  The Burden of Helminth Coinfections and Micronutrient Deficiencies in Patients with and without Leprosy Reactions: A Pilot Study in Minas Gerais, Brazil.

Authors:  Jessica K Fairley; Jose A Ferreira; Ana Laura Grossi de Oliveira; Thelma de Filippis; Maria Aparecida de Faria Grossi; Laura Pinheiro Chaves; Luiza Navarro Caldeira; Paola Souza Dos Santos; Rafaella Rodrigues Costa; Maria Cavallieri Diniz; Carolina Soares Duarte; Luiz Alberto Bomjardim Pôrto; Parminder S Suchdev; Deborah Aparecida Negrão-Corrêa; Fernanda do Carmo Magalhães; João Marcelo Peixoto Moreira; Adelino de Melo Freire Júnior; Mariana Costa Cerqueira; Uriel Kitron; Sandra Lyon
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

7.  Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.

Authors:  A Iyer; M Hatta; R Usman; S Luiten; L Oskam; W Faber; A Geluk; P Das
Journal:  Clin Exp Immunol       Date:  2007-11       Impact factor: 4.330

8.  Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report.

Authors:  Mariane M Stefani; Jackeline G Guerra; Ana Lucia M Sousa; Mauricio B Costa; Maria Leide W Oliveira; Celina T Martelli; David M Scollard
Journal:  BMC Infect Dis       Date:  2009-05-27       Impact factor: 3.090

9.  Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.

Authors:  Veronica Schmitz; Rhana Berto da Silva Prata; Mayara Garcia de Mattos Barbosa; Mayara Abud Mendes; Sheila Santos Brandão; Thaís Porto Amadeu; Luciana Silva Rodrigues; Helen Ferreira; Fabrício da Mota Ramalho Costa; Jessica Brandão Dos Santos; Fabiana Dos Santos Pacheco; Alice de Miranda Machado; José Augusto da Costa Nery; Mariana de Andrea Hacker; Anna Maria Sales; Roberta Olmo Pinheiro; Euzenir Nunes Sarno
Journal:  PLoS Negl Trop Dis       Date:  2016-08-24

10.  Leprosy reactions: coinfections as a possible risk factor.

Authors:  Ana Carolina F Motta; Karla Juliana Pereira; Daniela Chaves Tarquínio; Mariana Bellini Vieira; Karina Miyake; Norma Tiraboschi Foss
Journal:  Clinics (Sao Paulo)       Date:  2012-10       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.